These observations indicate that COX-2-mediated inflammation substantially contributes to relevant complications in subjects with metabolic syndrome and diabetes, further strengthening the importance of COX-2 activation in the development of obesity and obesity-related complications. This evidence concerns the gene PTGS2 and diabetes mellitus.